These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3106306)

  • 21. [Inducible cephalosporinase: study of Enterobacter hafniae].
    Grasso S; Meinardi G; de Carneri I
    G Ital Chemioter; 1985; 32(1):207-10. PubMed ID: 3913617
    [No Abstract]   [Full Text] [Related]  

  • 22. [Epidemiologic study on the prevalence of Enterobacter, Serratia and Pseudomonas strains, producers of cefoxitin-inducible beta-lactamases].
    Marone P; Concia E; Perversi L; Cruciani M
    Boll Ist Sieroter Milan; 1986; 65(5):368-73. PubMed ID: 3103651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-Lactamases of Pseudomonas aeruginosa.
    Livermore DM
    J Antimicrob Chemother; 1982 Sep; 10(3):168-71. PubMed ID: 6815154
    [No Abstract]   [Full Text] [Related]  

  • 24. [Beta-lactamases of clinical isolates of Enterobacteriaceae family].
    Polishko TM; Skliar TV; Krysenko OV; Vinnikov AI; Kudriavtseva VIe
    Mikrobiol Z; 2011; 73(2):20-5. PubMed ID: 21598655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
    Piddock LJ; Traynor EA
    J Antimicrob Chemother; 1991 Aug; 28(2):209-19. PubMed ID: 1778852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii.
    Cullmann W; Dick W
    Eur J Clin Microbiol; 1985 Feb; 4(1):34-40. PubMed ID: 3872794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance.
    Olson B; Weinstein RA; Nathan C; Kabins SA
    J Antimicrob Chemother; 1983 Apr; 11(4):299-310. PubMed ID: 6602122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AmpC beta-lactamases.
    Sahm DF; Storch G
    Pediatr Infect Dis J; 1998 May; 17(5):421-2. PubMed ID: 9613659
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams.
    Vu H; Nikaido H
    Antimicrob Agents Chemother; 1985 Mar; 27(3):393-8. PubMed ID: 3873215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Providing β-lactams a helping hand: targeting the AmpC β-lactamase induction pathway.
    Mark BL; Vocadlo DJ; Oliver A
    Future Microbiol; 2011 Dec; 6(12):1415-27. PubMed ID: 22122439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa.
    Sanders CC; Sanders WE; Goering RV
    Antimicrob Agents Chemother; 1983 Jul; 24(1):48-53. PubMed ID: 6414365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of chromatofocusing for separation of beta-lactamases. V. Inducible chromosomally mediated beta-lactamase of the Enterobacter cloacae 53 strain.
    Gál S; Frommer-Filep M; Toth-Martinez BL; Hernádi FJ; Kiss L
    J Chromatogr; 1985 Sep; 333(1):239-43. PubMed ID: 3877734
    [No Abstract]   [Full Text] [Related]  

  • 34. Selection frequency of resistant variants by various beta-lactam antibiotics in clinical Enterobacter cloacae isolates.
    Büscher KH; Cullmann W; Dick W; Stieglitz M
    Chemotherapy; 1987; 33(1):40-51. PubMed ID: 3493886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp.
    Dunne WM; Hardin DJ
    J Clin Microbiol; 2005 Dec; 43(12):5945-9. PubMed ID: 16333080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
    Then RL; Angehrn P
    Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas aeruginosa isolates with modified beta-lactamase inducibility: effects on beta-lactam sensitivity.
    Livermore DM; Williams RJ; Lindridge MA; Slack RC; Williams JD
    Lancet; 1982 Jun; 1(8287):1466-7. PubMed ID: 6123741
    [No Abstract]   [Full Text] [Related]  

  • 39. Chromosomal beta-lactam resistance in enterobacteria.
    Normark S; Lindquist S; Lindberg F
    Scand J Infect Dis Suppl; 1986; 49():38-45. PubMed ID: 3547624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of resistance to multiple beta-lactams in Enterobacter cloacae during treatment for neonatal meningitis with cefotaxime.
    Heusser MF; Patterson JE; Kuritza AP; Edberg SC; Baltimore RS
    Pediatr Infect Dis J; 1990 Jul; 9(7):509-12. PubMed ID: 2371083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.